HCM
MRK icon

Highview Capital Management’s Merck MRK Stock Holding History

Highview Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,569
Closed -$1.1M – 107
2023
Q2 		$1.1M Sell
9,569
-100
-1% -$11.4K 0.59% 51
2023
Q1 		$1.03M Buy
9,669
+192
+2% +$20.7K 0.59% 51
2022
Q4 		$1.05M Buy
9,477
+312
+3% +$31.9K 0.64% 47
2022
Q3 		$789K Buy
9,165
+2,015
+28% +$180K 0.59% 47
2022
Q2 		$652K Sell
7,150
-423
-6% -$37.5K 0.5% 54
2022
Q1 		$621K Buy
7,573
+3,564
+89% +$281K 0.4% 71
2021
Q4 		$307K Buy
+4,009
New +$319K 0.2% 89

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highview Capital Management's MRK Position: Q3 2023 in Review

Highview Capital Management sold out of Merck (MRK) in Q3 2023, closing a stake of 9,569 shares — an estimated $1.1M sold.

Highview Capital Management first reported a position in MRK in Q4 2021 and held it in 7 quarters. The position peaked at $1.1M in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Highview Capital Management reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Highview Capital Management sold 9,569 Merck shares in Q3 2023, an estimated $1.1M.
  • Highview Capital Management first reported a position in Merck in Q4 2021 and held it in 7 quarters.
  • Highview Capital Management's Merck position peaked at $1.1M in Q2 2023.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Highview Capital Management's 13F filing for Q3 2023, filed 20 Oct 2023.